The Glenn Foundation for Medical Research has awarded a $5 million grant to Stanford University to launch a new center on the biology of aging, focusing on the role of stem cells in the aging process.
The new Paul F. Glenn Laboratories for the Biology of Aging at Stanford University School of Medicine explores how stem cells change as an individual ages and how that contributes to the development of age-related diseases and disorders.
“There is something about age that predisposes us to disease,” said Thomas Rando, MD, PhD, a professor of neurology and neurological sciences who will serve as the director of the new center. “If we could somehow figure out the mechanisms of aging and are able to intervene, it would potentially offer therapy to a wide variety of diseases—not just cancer, heart disease or Alzheimer’s, but all of them.”
For information, visit the Paul F. Glenn Laboratories for the Biology of Aging.




